Zhang QI is a major player of the research team in university project, she has been responsible for coordinating with members at the center of structure biology at Indiana University and Tulane University on solving the crystal structure of the MDM2/ribosomal protein complex. She has been developing an elegant and sophisticated multigene expression system to co-express and co-purify the novel protein complex in order to explore the structures and functions of the p53 regulators MDM2 and the ribosomal proteins. She has obtained extensive experience in the screening for therapeutic candidates and the biochemical characterization of drug targets as a postdoctoral researcher at Indiana University School of Medicine. Dr Zhang collaborated efficiently with scientists from various areas, such as molecular biology, cellular biology, biochemistry, computer-aided drug design, combinatorial chemistry, clinical pharmacology, drug analysis and high-throughput screening, facilitating the progression of drug discovery projects. Her research will be complementary to the mission of Tulane School of Medicine and Tulane Cancer Center in discovering cures for cancer diseases and building the essential bridge between basic research and clinical research to accomplish this objective.

Targeting the p53-pathway for the treatment of cancer; Study of p53 regulators by a combination of biochemical and structural analyses.

Dr. Campagna completed his B.S. in Chemistry at North Carolina State University in 2000 and conducted research with Prof. Jonathan S. Lindsey on the chemical synthesis of bacterial chromosomes. He received his Ph.D. from Princeton University in 2006, after working with Prof. Martin F. Semmelhack on a joint project with Profs. Bonnie L. Bassler and Frederick M. Hughson to characterize the chemical properties of an inter-species bacterial signaling molecule, autoinducer-2. Dr. Campagna then performed post-doctoral fellow research with Prof. Joshua D. Rabinowitz at the Lewis-Sigler Institute for Integrative Genomics at Princeton University where he developed mass spectrometric methods for the identification of novel biochemical pathways and natural products from whole cell extracts. He joined the Chemistry Department at UT Knoxville in August 2007.

organic synthesis, combinatorial methods, and analytical techniques, such as tandem liquid chromatography-mass spectrometry and nuclear magnetic resonance, to answer biologically relevant questions at the molecular level.

Protein folding, aggregation, complexes; proteomics, mass spectrometry of non-covalent interactions.

Sihe Wang, PhD is Section Head and Medical Director of Clinical Biochemistry and Director ofClinical Biochemistry Fellowship Training Program at Cleveland Clinic. He chairs clinical chemistry integration team for the Cleveland Clinic Health System which includes one Florida hospital, eight community hospitals and eighteen family health centers in Northeast Ohio. Additionally, he is a Clinical Chemistry Professor, Cleveland State University. His expertise includes general clinical chemistry and clinical application of mass spectrometry.Sihe is a diplomate of the American Board of Clinical Chemistry since 2005 and a fellow of the National Academy of Clinical Biochemistry since 2006. Sihe is a member of the American Association for Clinical Chemistry (AACC) since 2000. He served as chair of AACC Northeast Ohio Section in 2008 and 2009 and the president of North American Chinese Clinical Chemistry Association (NACCCA) 2008-2009. Currently he serves as historian for NACCCA, treasurer for the Pediatric and Maternal Fetal Division of AACC delegate for AACC Northeast Ohio section, commissioner for the Commission on Accreditation in Clinical Chemistry (ComACC), and member of AACC's Strategies Online Editorial Advisory Board. Sihe has authored over 180 journal articles, book chapters, and abstracts. He also serves on several editorial boards of peer reviewed journals.

Chromatography and mass spectrometry for specialty testing, general clinical chemistry, new biomarkers for cardiovascular or kidney diseases

Professor Shaorong Liu earned his Ph. D. degree in 1995 at Texas Tech University, focusing on the development of miniaturized chemical analysis systems (supervised by Professor Sandy Dasgupta). After postdoc training with Prof. Barry Karger at Northeastern University, and Professor Rich Mathies at the University of California at Berkeley, Dr. Liu joined Molecular Dynamics (now part of GE HealthCare) in Sunnyvale, California in 1998. In 2000, he became the Director of the Department of Technology Development. In 2002, Dr. Liu joined the Department of Chemistry and Biochemistry at Texas Tech University as an Associate Professor, and was tenured and promoted to Full Professor in 2007. Since 2008, Dr. Liu has been a Professor in the Department of Chemistry and Biochemistry at University of Oklahoma. In the past two decades, Dr. Liu has secured >$10 million from federal agencies, published >90 peer-reviewed articles in prestigious journals (including Proc. Natl. Acad. Sci. USA, J. Am. Chem. Soc., Angew. Chem. Int. Ed., Nano Lett., Anal. Chem., etc.), received research awards including the 2006 International Nano 50 Award, the 2006 Chancellor’s Council Distinguished Research Award, and the 2013 Regents’ Award for Superior Research and Creative Activity. Dr. Liu has also earned an EMBA degree in 2001.

Development and application of microfluidic systems; bio-separation and bio-analysis; analytical Instrumentation

Dr Rogatsky is a senior faculty member at Albert Einstein College of Medicine (NY, Bronx) and director of mass spectrometry at Biomarker Analytical Resource Core as part of the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore . He has worked in the field of chromatography more than 20 years. Since 2001 his work has been within the service of the field of clinical mass spectrometry. During last 10 years (from 2004) Dr Rogatsky published 25 scientific papers in per-reviewed journals (mostly as the first author) and presented over 50 posters and lectures. Currently Dr Rogatsky serve as the Editor-in-Chief for the Journal of Chromatography and Separation Techniques (OMICS publishing group). Eduard Rogatsky completed his M.Sc (physical chemistry) in Belarus State University (former USSR) in 1990. In 1998 has completed PhD in bioanalytical chemistry (Bar-Ilan University, Israel). At the end of 1999 he started post-doctorate at Albert Einstein College of medicine and since 2001 joined faculty. Currently his holds a title of Research Associate professor of Medicine.

Design and development of ultra sensitive LC/MS, analytical assay of clinical biomarker and metabolomics, analysis of peptide hormone and protein, design and development of multi-dimentional chromatography platform.

Dr. Rongying research focuses on the development of novel complex materials with intriguing physical properties, such as new phases that exist on the edge of instabilities (unconventional superconductivity, quantum critical phenomena, heavy – Fermion behavior, thermoelectricity etc.). Thus, her research effort is devoted to (1) “science-driven” synthesis and (2) investigation of basic physical properties (charge, spin and heat transport, magnetization, specific heat etc.).

Chrys Wesdemiotis received his Ph.D. degree with Helmut Schwarz at Technische Universität Berlin in 1979. He was a postdoctoral fellow with Fred W. McLafferty at Cornell University in 1980. After completing his military service in Greece (1981-3), he returned to Cornell as a senior research associate (1983-9). In 1989, he joined the faculty of the University of Akron, where he currently is Distinguished Professor of Chemistry, Polymers Science, and Integrated Bioscience. Research in the Wesdemiotis group focuses on the development and applications of multi-dimensional mass spectrometry methods for the characterization of new synthetic polymers and polymer-biomolecule conjugates and interfaces. Wesdemiotis served as a Member-at-Large for Education in the Board of Directors of the American Society for Mass Spectrometry (ASMS) and is a Fellow of the American Association for the Advancement of Science (AAAS). He is an Editor of the European Journal of Mass Spectrometry and a member of the Editorial Boards of the Journal of the American Society for Mass Spectrometry, International Journal of Mass Spectrometry, and Mass Spectrometry Reviews.

Mass spectrometry and tandem mass spectrometry: fundamental studies and analytical applications to macromolecules.

Marek M. Kowalczuk received his Ph.D. degree in 1984 from the Faculty of Chemistry, Silesian University of Technology, and D.Sc. degree in 1994 at the same University. He was a visiting lecturer at the University of Massachusetts in Amherst, MA, U.S.A. in 1990 and Marie Curie EU fellow at the University of Bologna, Italy. Currently, he is professor at the University of Wolverhampton, UK and at the Centre of Polymer and Carbon Materials, Polish Academy of Sciences, Zabrze, Poland. He is the author and co-author of over 120 scientific papers and a score of patents.

Novel mass spectrometry techniques for analysis of polymers at the molecular level, mechanisms of anionic polymerization related to the synthesis of biodegradable polymers possessing desired architecture, forensic engineering of biodegradable and functional polymers.

Dr. Sharma is Analytical Scientist at International AIDS Vaccine Initiative (IAVI), USA. Dr. Sharma received a M.S. in Chemistry from University of Connecticut and a Ph.D. in Analytical Chemistry from the Northeastern University, Boston under the direction of Professor Paul Vouros. Dr. Sharma Ph.D. research was focused on the LC-MS/MS method development and software development for the identification and sequencing of oligonucleotide adduct. He began work as a Scientist in Novartis Vaccines in 2012 and worked on the Analytical method development and characterization (LC-MS/MS) for HIV.C gp120 glycoprotein.

Glycoprotein characterization, HIV gp120 characterization, DNA adducts, oligonucleotide adducts, oligonucleotide sequencing software.

Professor Huan-Tsung Chang is currently a professor of National Taiwan University. He is a Fellow of the Royal Society of Chemistry. He obtained his Ph. D from the Department of Chemistry, Iowa State University in 1994. He has been published more than 250 papers. His research interests include (1) Green synthesis of nanomaterials (NMs); (2) NMs based mass spectrometry; (3) Functional NMs for sensing and cell imaging; (4) Functional NMs as potential drugs and antibacterial agents; (5) NMs based fuel cells; (6) Quantum dots solar cells; and (7) Separation

Green synthesis of nanomaterials, Quantum dots solar cells, Functional NMs as potential drugs and antibacterial agents,NMs based fuel cells.